Wu, W., Liu, Y., Zeng, S., Han, Y., & Shen, H. (2021). Intratumor heterogeneity: The hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes. Journal of Hematology & Oncology, 14(1), 1. https://doi.org/10.1186/s13045-021-01166-3
Chicago Style (17th ed.) CitationWu, Wantao, Yihan Liu, Shan Zeng, Ying Han, and Hong Shen. "Intratumor Heterogeneity: The Hidden Barrier to Immunotherapy Against MSI Tumors from the Perspective of IFN-γ Signaling and Tumor-infiltrating Lymphocytes." Journal of Hematology & Oncology 14, no. 1 (2021): 1. https://doi.org/10.1186/s13045-021-01166-3.
MLA (9th ed.) CitationWu, Wantao, et al. "Intratumor Heterogeneity: The Hidden Barrier to Immunotherapy Against MSI Tumors from the Perspective of IFN-γ Signaling and Tumor-infiltrating Lymphocytes." Journal of Hematology & Oncology, vol. 14, no. 1, 2021, p. 1, https://doi.org/10.1186/s13045-021-01166-3.